# Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X

> **NCT04185636** · — · UNKNOWN · sponsor: **MolecuLight Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Skin Graft (Allograft)(Autograft) Failure

## Interventions

- **DEVICE:** MolecuLight i:X imaging

## Key facts

- **NCT ID:** NCT04185636
- **Lead sponsor:** MolecuLight Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04185636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04185636, "Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04185636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*